Fesoterodine dose response in subjects with overactive bladder syndrome.
| Publicado en: | Urology Vol. 71; no. 5; pp. 839 - 844 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | clinical trial research Journal Article |
| Publicado: |
Elsevier B.V.
May2008
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105708305&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105708305 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00904295 1YG jtl: Urology issn: 00904295 maglogo: N pubinfo: dt: May2008 vid: 71 iid: 5 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 105708305 2010105235 10.1016/j.urology.2007.12.017 NLM18342923 105708305 ppf: 839 ppct: 5 formats: tig: atl: Fesoterodine dose response in subjects with overactive bladder syndrome. aug: au: Khullar V Rovner ES Dmochowski R Nitti V Wang J Guan Z affil: St. Mary's Hospital, Imperial College, London, United Kingdom. vik.khullar@imperial.ac.uk sug: subj: Benzhydryl Compounds Administration and Dosage Overactive Bladder Drug Therapy Adult Aged Aged, 80 and Over Clinical Trials Dose-Response Relationship, Drug Female Male Middle Age Human Adult: 19-44 years Aged: 65+ years Aged, 80 & over Middle Aged: 45-64 years Female Male pubtype: Academic Journal doctype: clinical trial research Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|